Magnesium

Low-cost Interventions Could Ease the Burden of Diabetes, according to the Journal of American Physicians and Surgeons

Retrieved on: 
Wednesday, December 13, 2023
Liver, AAPS, Risk, Resveratrol, Physician, City, Glycemic index, Weight loss, Low-fat diet, Probiotic, Magnesium, Insulin, Diabetes, Metformin, Fasting, Berberine, Melatonin, Insulin resistance, Patient, Lifestyle (social sciences), Journal

Management requires chronic medication use, with the expectation that this will be required life-long, creating a huge burden on medical systems.

Key Points: 
  • Management requires chronic medication use, with the expectation that this will be required life-long, creating a huge burden on medical systems.
  • Recently, however, novel low-cost noninvasive treatment approaches demonstrate promise for the long-term remission of T2DM symptoms, write Paul Marik , M.D., and colleagues in the winter issue of the Journal of American Physicians and Surgeons.
  • Abnormalities that contribute to T2DM include insulin resistance, impaired insulin secretion, increased glucose production in the liver, and other factors.
  • “The suggested protocols need further study, and funding is needed for holistic diabetes management in medical systems.”
    The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.

Intrepid Engages Pickering Energy Partners as Lithium Advisor

Retrieved on: 
Tuesday, December 12, 2023
Lithium, Potash, Intrepid, IPI, Intrepid Potash, Potassium, Executive, Magnesium, CO, PEP, Pond

Denver, CO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. ("Intrepid," "we," or "our") (NYSE:IPI) today announced it engaged Pickering Energy Partners LP (“Pickering” or “PEP”) to advise on maximizing the value of the lithium resource at its mine in Wendover, Utah.

Key Points: 
  • Denver, CO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. ("Intrepid," "we," or "our") (NYSE:IPI) today announced it engaged Pickering Energy Partners LP (“Pickering” or “PEP”) to advise on maximizing the value of the lithium resource at its mine in Wendover, Utah.
  • Pickering has established itself as a leader and trusted advisor in the energy space and we are excited to partner together and evaluate promising new direct lithium extraction (“DLE”) technologies to recover lithium from our brine and create value for Intrepid and our shareholders."
  • “The opportunity for Intrepid to develop its lithium resource is compelling as its existing potash operation and infrastructure provide a clear path to production in the rapidly growing lithium industry,” said Dan Pickering, Chief Investment Officer of PEP.
  • In addition to potash and salt, our brine resource also contains magnesium, lithium, and other associated minerals.

Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD

Retrieved on: 
Wednesday, December 6, 2023
Quality of life, CYP, Kidney, Risk, Heartburn, Enzyme inhibitor, FDA, TIN, Hypertension, Achlorhydria, Magnesium, Liver, PPI, SJS, Magnesium deficiency, Chest pain, Atazanavir, Endoscopy, Impairment, SCAR, Vitamin B12, Malabsorption, Absorption, PDUFA, CDAD, Calcium, New Drug Application, Gastritis, Enzyme, Food and Drug Administration, Clostridioides, Vonoprazan, Patient, Hip, Hypokalemia, Food, Polyp, GERD, Nelfinavir, Toxicity, EGFR, Wrist, Diarrhea, Hypocalcemia, NDA, Abdominal pain, Urinary tract infection, Hypersensitivity, Stevens–Johnson syndrome, Glomus tumor, Spine, Indigestion, Drug, CGA, Lactation, Pharmaceutical industry

The FDA has assigned the application a standard 10-month review with a Prescription Drug User Fee Act (PDUFA) target action date of July 19, 2024.

Key Points: 
  • The FDA has assigned the application a standard 10-month review with a Prescription Drug User Fee Act (PDUFA) target action date of July 19, 2024.
  • “Non-Erosive GERD represents a substantial segment of the U.S. GERD population, affecting millions of individuals and impacting their quality of life.
  • Symptoms impact overall quality of life and can include episodic heartburn, especially at night, regurgitation, problems swallowing, and chest pain.
  • for the maintenance of healing of all grades of Erosive GERD and relief of heartburn associated with Erosive GERD in adults.

TRANSFORMA PROVIDES UPDATE ON MAC NICKEL PROPERTY: ROCK SAMPLING ASSAY RESULTS AND REDUCED AREA

Retrieved on: 
Wednesday, November 29, 2023
Chrome, FPX, Magnesium, MAC, DTR, Rare-earth element

Vancouver, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Transforma Resources Corporation (the “Company” or “Transforma”) is pleased to announce results from the analysis of fifty-seven (57) rock samples taken from the southwest portion of the MAC Property, which is located 12 km west of FPX Nickel’s Baptiste Nickel Deposit.  

Key Points: 
  • Vancouver, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Transforma Resources Corporation (the “Company” or “Transforma”) is pleased to announce results from the analysis of fifty-seven (57) rock samples taken from the southwest portion of the MAC Property, which is located 12 km west of FPX Nickel’s Baptiste Nickel Deposit.
  • Among the key highlights, nineteen (19) rock samples have exhibited assays above 0.2% Ni (0.2%), with a high of 2600 ppm (0.26%) Ni content.
  • Another sample recorded 26.3% Magnesium, while several others returned Magnesium levels around 25%, with 40 others exceeding 15% Mg.
  • The MAC Property is host to a large Molybdenum/Copper Porphyry Deposit, which the Company also looks forward to an opportunity to explore.

Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn

Retrieved on: 
Tuesday, November 28, 2023
HIV-1, Risk, Heartburn, MOA, Enzyme inhibitor, Potassium, FDA, Magnesium, Nausea, PPI, Inflammation, Prescription, Esophagus, Bone fracture, Skin, Chills, Extrapyramidal system, Fever, Vitamin, Breast milk, Infection, Diarrhea, Helicobacter pylori, Indigestion, Bleeding, Disease, Muscle weakness, Tongue, Calcium, Acid, University, Human, Pharmacy, Clostridioides, Vonoprazan, Urine, Hip, B-12, Food, Polyp, Esophagitis, GERD, Chronic pain, Blood, Dizziness, Blister, Gastroesophageal reflux disease, Tablet, Vitamin B12, Scar, Patient, Wrist, Medicine, Seizure, HIV, Stomach, Lymph, Allergy, Clostridioides difficile, Rash, Weakness, Urinary tract infection, Hypoesthesia, Week, Myalgia, Spine, Spasm, Kidney, Face, Rilpivirine, Lansoprazole, Pharmaceutical industry

“We are thrilled to announce the commercial availability of our first-in-class medication, VOQUEZNA, now available for the millions of people in the U.S. suffering from Erosive GERD,” said Martin Gilligan, Chief Commercial Officer at Phathom Pharmaceuticals.

Key Points: 
  • “We are thrilled to announce the commercial availability of our first-in-class medication, VOQUEZNA, now available for the millions of people in the U.S. suffering from Erosive GERD,” said Martin Gilligan, Chief Commercial Officer at Phathom Pharmaceuticals.
  • “Erosive GERD is a highly prevalent condition affecting over 20 million people in the U.S.,3,4 many of whom experience troubling symptoms, including painful heartburn.
  • Phathom is offering programs for eligible patients who face coverage or affordability issues, including co-pay assistance for patients with commercial insurance.
  • for up to 6 months to maintain healing of Erosive Acid Reflux and for relief of heartburn related to Erosive Acid Reflux.

Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements’ Company with Fast-Growing Potential

Retrieved on: 
Tuesday, November 21, 2023
Ginkgo biloba, Powder, Capsule, Probiotic, Zinc, Magnesium, True–DTAC merger, B2B, Oil, Plant, GMP, OTCQB, Ministry, IBOT, Tablet, Growth, Spirulina

iBOT, a nutritional supplements’ company with innovative botanical solutions, owns a GMP-certified manufacturing facility approved by the Israeli Ministry of Health.

Key Points: 
  • iBOT, a nutritional supplements’ company with innovative botanical solutions, owns a GMP-certified manufacturing facility approved by the Israeli Ministry of Health.
  • According to iBOT, sales of approximately 3.3 million NIS ($850K) are estimated for 2023 only from sales of private label in Israel.
  • said Ora Elharar Soffer, Chairman and CEO of Citrine Global Corp.
    Citrine Global and iBOT are related parties, where Citrine Global has a previous pre-emption right to acquire 51% of iBOT and joint venture and manufacturing agreements.
  • Ms. Ora Elharar Soffer, Citrine Global CEO and Chairman, is also a director in iBOT.

Standard Lithium Provides Comprehensive Results of Its Fully Optimized and Proven DLE Process

Retrieved on: 
Monday, November 20, 2023
Lithium, Dorado, Plant, DLE, Demonstration plant, Potassium, Magnesium, LSS, FRA, Calcium, Knowledge, SLI, Lithium chloride, Boron, Sodium

EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.

Key Points: 
  • EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.
  • Standard Lithium's Demonstration Plant is the only truly large-scale, continuously operating DLE plant in North America.
  • Both studies incorporate the LiPROTM LSS (DLE) process developed in collaboration with Koch Technology Solutions, LLC (“KTS”).
  • Lithium Recovery Efficiency: During a representative period of performance over July and August 2023, the LiPROTM LSS (DLE) process achieved an average lithium recovery of 96.1% from the continuous incoming brine flow.

Standard Lithium Provides Comprehensive Results of Its Fully Optimized and Proven DLE Process

Retrieved on: 
Monday, November 20, 2023
Lithium, Dorado, Plant, DLE, Demonstration plant, Potassium, Magnesium, LSS, FRA, Calcium, Knowledge, SLI, Lithium chloride, Boron, Sodium

EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.

Key Points: 
  • EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.
  • Standard Lithium's Demonstration Plant is the only truly large-scale, continuously operating DLE plant in North America.
  • Both studies incorporate the LiPROTM LSS (DLE) process developed in collaboration with Koch Technology Solutions, LLC (“KTS”).
  • Lithium Recovery Efficiency: During a representative period of performance over July and August 2023, the LiPROTM LSS (DLE) process achieved an average lithium recovery of 96.1% from the continuous incoming brine flow.

Christmas with "I Love Fruit & Veg from Europe": Gift a Citrus Tiramisu - a delightful and healthy holiday treat

Retrieved on: 
Saturday, December 23, 2023
European Commission, Immune system, Human, Friends, Magnesium, Chocolate, Calcium, Civil service commission, Folate, Phosphorus, Infection, Vitamin A, Christmas, Selenium

ROME, Dec. 23, 2023 /PRNewswire/ -- Christmas is just around the corner, bringing festive days and the best fruits of the season. With the project "I Love Fruit & Veg from Europe," promoted by the producer organizations Agritalia, A.O.A., La Deliziosa, Meridia, and Terra Orti, and co-financed by the European Commission, lunches and dinners can be rich, delicious, and healthy. Our gift under the Christmas tree this year is a Citrus Tiramisu, created by chef Pierpaolo Giorgio. It is the perfect conclusion to a Christmas meal featuring fruits from our holiday menus - oranges, lemons, and mandarins.

Key Points: 
  • ROME, Dec. 23, 2023 /PRNewswire/ -- Christmas is just around the corner, bringing festive days and the best fruits of the season.
  • With the project "I Love Fruit & Veg from Europe," promoted by the producer organizations Agritalia, A.O.A., La Deliziosa, Meridia, and Terra Orti, and co-financed by the European Commission, lunches and dinners can be rich, delicious, and healthy.
  • Our gift under the Christmas tree this year is a Citrus Tiramisu, created by chef Pierpaolo Giorgio.
  • It is the perfect conclusion to a Christmas meal featuring fruits from our holiday menus - oranges, lemons, and mandarins.

Electra Appoints Francois Perras as Chief Commercial Officer

Retrieved on: 
Thursday, December 14, 2023
Mining, Minerals, Environment, Manufacturing, Sustainability, Natural Resources, Green Technology, Steel, Iron, Carbon, DRI, Metallurgy, ArcelorMittal, EAF, CCO, Lead, Magnesium, Management

Electra , a clean iron company with a solution to decarbonize iron and steelmaking, has appointed Francois Perras as Chief Commercial Officer (CCO).

Key Points: 
  • Electra , a clean iron company with a solution to decarbonize iron and steelmaking, has appointed Francois Perras as Chief Commercial Officer (CCO).
  • Concurrently, Simon Wandke will transition from his role as the CCO to the Chair of Electra's Advisory Board and Advisor to the CEO.
  • Most recently, Perras was CEO of Tergeo Minerals, a company focused on extracting magnesium and amorphous silica from mine tailings.
  • Perras has extensive expertise in upstream agglomerated iron ores, direct-reduced ironmaking (DRI) and electric-arc furnace (EAF) steelmaking, and downstream markets and applications.